Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study
Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study
Der‐Cherng Tarng, Fei‐Yuan Hsiao, Elise Tan, Chih‐Yuan Wang et al.
Citations
22 citations
Journal
The Lancet Healthy Longevity
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
7.87
article
Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study